These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12193983)

  • 21. Coagulation factor XIII and atherothrombosis. A mini-review.
    Cucuianu M; Dican L
    Rom J Intern Med; 2003; 41(4):339-55. PubMed ID: 15526518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clot stabilization for the prevention of bleeding.
    Rojkjaer LP; Rojkjaer R
    Hematol Oncol Clin North Am; 2007 Feb; 21(1):25-32. PubMed ID: 17258116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cleavage of factor XIII by human neutrophil elastase results in a novel active truncated form of factor XIII A subunit.
    Bagoly Z; Fazakas F; Komáromi I; Haramura G; Tóth E; Muszbek L
    Thromb Haemost; 2008 Apr; 99(4):668-74. PubMed ID: 18392324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluating factor XIII specificity for glutamine-containing substrates using a matrix-assisted laser desorption/ionization time-of-flight mass spectrometry assay.
    Doiphode PG; Malovichko MV; Mouapi KN; Maurer MC
    Anal Biochem; 2014 Jul; 457():74-84. PubMed ID: 24751466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro evaluation of clot quality and stability in a model of severe thrombocytopenia: effect of fibrinogen, factor XIII and thrombin-activatable fibrinolysis inhibitor.
    Shenkman B; Einav Y; Livnat T; Budnik I; Martinowitz U
    Blood Transfus; 2014 Jan; 12(1):78-84. PubMed ID: 24333083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet-associated factor XIII in platelet activation, adhesion, and clot stabilization.
    Devine DV; Bishop PD
    Semin Thromb Hemost; 1996; 22(5):409-13. PubMed ID: 8989824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteolytic and nonproteolytic activation mechanisms result in conformationally and functionally different forms of coagulation factor XIII A.
    Anokhin BA; Dean WL; Smith KA; Flick MJ; Ariëns RAS; Philippou H; Maurer MC
    FEBS J; 2020 Feb; 287(3):452-464. PubMed ID: 31407850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FXIII polymorphisms, fibrin clot structure and thrombotic risk.
    Kobbervig C; Williams E
    Biophys Chem; 2004 Dec; 112(2-3):223-8. PubMed ID: 15572253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factor XIIIa generation assay: a tool for studying factor XIII function in plasma.
    Dodt J; Volkers P; Seitz R
    Anal Biochem; 2013 Aug; 439(2):145-51. PubMed ID: 23611748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Down-regulation of activated factor XIII by polymorphonuclear granulocyte proteases within fibrin clot.
    Bagoly Z; Haramura G; Muszbek L
    Thromb Haemost; 2007 Aug; 98(2):359-67. PubMed ID: 17721618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hierarchies in the binding of human factor XIII, factor XIIIa, and endothelial cell transglutaminase to human plasma fibrinogen, fibrin, and fibronectin.
    Achyuthan KE; Rowland TC; Birckbichler PJ; Lee KN; Bishop PD; Achyuthan AM
    Mol Cell Biochem; 1996 Sep; 162(1):43-9. PubMed ID: 8905624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perturbations in factor XIII resulting from activation and inhibition examined by solution based methods and detected by MALDI-TOF MS.
    Sabo TM; Brasher PB; Maurer MC
    Biochemistry; 2007 Sep; 46(35):10089-101. PubMed ID: 17691819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factor XIII: a coagulation factor with multiple plasmatic and cellular functions.
    Muszbek L; Bereczky Z; Bagoly Z; Komáromi I; Katona É
    Physiol Rev; 2011 Jul; 91(3):931-72. PubMed ID: 21742792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factor XIII in severe sepsis and septic shock.
    Zeerleder S; Schroeder V; Lämmle B; Wuillemin WA; Hack CE; Kohler HP
    Thromb Res; 2007; 119(3):311-8. PubMed ID: 16574200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of Fibrinolysis by Coagulation Factor XIII.
    Rijken DC; Uitte de Willige S
    Biomed Res Int; 2017; 2017():1209676. PubMed ID: 28761875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating the Effects of Fibrinogen αC Mutations on the Ability of Factor XIII to Crosslink the Reactive αC Glutamines (Q237, Q328, Q366).
    Mouapi KN; Wagner LJ; Stephens CA; Hindi MM; Wilkey DW; Merchant ML; Maurer MC
    Thromb Haemost; 2019 Jul; 119(7):1048-1057. PubMed ID: 31055797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombin activatable fibrinolysis inhibitor (TAFI)--how does thrombin regulate fibrinolysis?
    Bouma BN; Mosnier LO
    Ann Med; 2006; 38(6):378-88. PubMed ID: 17008302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrinogen and factor XIII at the intersection of coagulation, fibrinolysis and inflammation.
    Hoppe B
    Thromb Haemost; 2014 Oct; 112(4):649-58. PubMed ID: 25182841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of Factor XIII β-Sandwich Residues Mediating Glutamine Substrate Binding and Activation Peptide Cleavage.
    Mohammed RDS; Piell KM; Maurer MC
    Thromb Haemost; 2024 May; 124(5):408-422. PubMed ID: 38040030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of factor XIII activation by an anti-peptide monoclonal antibody.
    Lukacova D; Matsueda GR; Haber E; Reed GL
    Biochemistry; 1991 Oct; 30(42):10164-70. PubMed ID: 1681898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.